Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024 2024-09-16 18:00
Akeso's Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024 2024-09-16 15:35
ESMO 2024 - ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients 2024-09-15 17:53
Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024 2024-09-15 15:10
Dialogue with CGT Leaders! You Are Invited to Join the "2024 GenScript Biotech Global Forum•London" to Discuss the Future Together 2024-09-15 06:53
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration 2024-09-14 19:43
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 2024-09-14 16:06
NiceTop™️ Unveils New Hair Growth Supplement Amid Product Line Expansion 2024-09-14 12:21
MediLink presents YL201 (B7H3 ADC) at ESMO 2024, with over 6-months PFS in SCLC, and showing pan-tumor benefits 2024-09-14 01:00
111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation 2024-09-13 19:30
US FDA Grants RPD Designation to Senhwa Biosciences Silmitasertib for Pediatric Neuroblastoma 2024-09-13 13:49
Nona Biosciences Enters into Collaboration Agreement with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies 2024-09-13 09:27
Stapokibart Was Granted Marketing Approval From National Medical Products Administration For The Treatment Of Moderate-to-severe Atopic Dermatitis in Adults 2024-09-13 00:07
SECuRE trial advances: No dose limiting toxicities and strong preliminary efficacy data in first multi-dose cohort 2024-09-12 21:03
E-Home Household Services Holdings Limited's subsidiary Zhongrun Pharmaceutical and New Zealand's NBL Pharmaceuticals Sign Cooperation Agreement to Expand International Markets 2024-09-12 21:00
GenScript Appoints New Board Members to Drive Global Growth 2024-09-12 19:34
South Korean Startup DoctorPresso Launches Groundbreaking App That Detects Depression Through Voice 2024-09-12 16:26
Bloomage 2024 Mid-Year Report: International Raw Materials Sales Surpass Domestic Chinese Market's for the First Time 2024-09-11 21:00
Collagen tripeptides: a new era of collagen drinks 2024-09-11 17:00
TCI Revolutionizes Weight Management with Breakthrough GLP-1 Innovation 2024-09-11 15:56
1 11 12 13 14 15 812